HTRA1 | HtrA serine peptidase 1 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted secreted proteins
| | | | | Mixed |
IDE | Insulin-degrading enzyme | Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
KLK10 | Kallikrein-related peptidase 10 | Cancer-related genes Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
KLK13 | Kallikrein-related peptidase 13 | Cancer-related genes Enzymes Predicted secreted proteins
| | | | | Tissue enriched |
KLK2 | Kallikrein-related peptidase 2 | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
KLK3 | Kallikrein-related peptidase 3 | Cancer-related genes Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
KLK4 | Kallikrein-related peptidase 4 | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
KLK5 | Kallikrein-related peptidase 5 | Cancer-related genes Enzymes Predicted secreted proteins
| | | | | Tissue enriched |
KLK6 | Kallikrein-related peptidase 6 | Cancer-related genes Enzymes Mitochondrial proteins Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
KLK7 | Kallikrein-related peptidase 7 | Cancer-related genes Enzymes Predicted intracellular proteins Predicted secreted proteins
| | | | | Group enriched |
KLK8 | Kallikrein-related peptidase 8 | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Group enriched |
LACTB | Lactamase, beta | Enzymes Mitochondrial proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
LAP3 | Leucine aminopeptidase 3 | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
LGMN | Legumain | Cancer-related genes Enzymes Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
LMLN | Leishmanolysin-like (metallopeptidase M8 family) | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Mixed |
LONP1 | Lon peptidase 1, mitochondrial | Enzymes Mitochondrial proteins Predicted intracellular proteins
| | | | | Expressed in all |
LPA | Lipoprotein, Lp(a) | Candidate cardiovascular disease genes Enzymes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
LTA4H | Leukotriene A4 hydrolase | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
MALT1 | Mucosa associated lymphoid tissue lymphoma translocation gene 1 | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
MASP1 | Mannan-binding lectin serine peptidase 1 (C4/C2 activating component of Ra-reactive factor) | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
MASP2 | Mannan-binding lectin serine peptidase 2 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Tissue enriched |
MBTPS1 | Membrane-bound transcription factor peptidase, site 1 | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
MBTPS2 | Membrane-bound transcription factor peptidase, site 2 | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
MEP1A | Meprin A, alpha (PABA peptide hydrolase) | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
MEP1B | Meprin A, beta | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
METAP1 | Methionyl aminopeptidase 1 | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
METAP1D | Methionyl aminopeptidase type 1D (mitochondrial) | Enzymes Predicted intracellular proteins
| | | | | Expressed in all |
METAP2 | Methionyl aminopeptidase 2 | Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
MIPEP | Mitochondrial intermediate peptidase | Enzymes Mitochondrial proteins Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
MME | Membrane metallo-endopeptidase | Cancer-related genes Candidate cardiovascular disease genes CD markers Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
MMP10 | Matrix metallopeptidase 10 (stromelysin 2) | Cancer-related genes Enzymes FDA approved drug targets Predicted secreted proteins
| | | | | Tissue enriched |
MMP15 | Matrix metallopeptidase 15 (membrane-inserted) | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Mixed |
MMP8 | Matrix metallopeptidase 8 (neutrophil collagenase) | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
MMP9 | Matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
MYSM1 | Myb-like, SWIRM and MPN domains 1 | Enzymes Predicted intracellular proteins
| | | | | Expressed in all |
NAALADL2 | N-acetylated alpha-linked acidic dipeptidase-like 2 | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Mixed |
NAPSA | Napsin A aspartic peptidase | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
NPEPL1 | Aminopeptidase-like 1 | Enzymes Predicted intracellular proteins
| | | | | Expressed in all |
NPEPPS | Aminopeptidase puromycin sensitive | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
NRD1 | Nardilysin (N-arginine dibasic convertase) | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
OTUB1 | OTU deubiquitinase, ubiquitin aldehyde binding 1 | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
OTUB2 | OTU deubiquitinase, ubiquitin aldehyde binding 2 | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
OTUD7B | OTU deubiquitinase 7B | Enzymes Predicted intracellular proteins
| | | | | Expressed in all |
PA2G4 | Proliferation-associated 2G4, 38kDa | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
PAPPA | Pregnancy-associated plasma protein A, pappalysin 1 | Cancer-related genes Candidate cardiovascular disease genes Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
PAPPA2 | Pappalysin 2 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
PARK7 | Parkinson protein 7 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
PARL | Presenilin associated, rhomboid-like | Enzymes Mitochondrial proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
PCSK2 | Proprotein convertase subtilisin/kexin type 2 | Enzymes Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
PCSK5 | Proprotein convertase subtilisin/kexin type 5 | Enzymes Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |